蚂蚁vnpapp官网下载

蚂蚁vnpapp官网下载

 

We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, Pacific Biosciences has created a powerful technology platform called single molecule, real-time (SMRT™) technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform the understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.

蚂蚁vnpapp官网下载

EVENTS & PRESENTATIONS

xf5.app加速器

Pacific Biosciences of California, Inc. 2022 Annual Meeting of Stockholders

Aug 4, 2022 ios加速器

ios加速器

土豆加速器app
There are no items to display.
ios加速器

Pacific Biosciences and Asuragen Collaborate to Develop Assays for Carrier Screening and other Applications Based on SMRT Sequencing Technology and AmplideX PCR Chemistry

Aug 03, 2022

Pacific Biosciences of California, Inc. Second Quarter 2022 Financial Results Call

Jul 24, 2022

STOCK QUOTE

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor
Contact

土豆加速器app

1305 O’Brien Drive

Menlo Park, CA  94025

ir@pacb.com